Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen

It’s just a first step, but this new Alzheimer’s drug could be a huge breakthrough

Recent lecanemab trials are reason for hope, although health services may struggle to deliver treatments, says dementia researcher Jonathan Schott

The Guardian - UK

Lecanemab: new Alzheimer’s drug hailed as ‘beginning of the end’ for disease

A ground-breaking drug has been found to slow cognitive decline in people with Alzheimer’s - with experts hailing it a breakthrough that “can meaningfully change the course of the disease”.

Evening Standard

Breakthrough Alzheimer's drug hailed as 'beginning of the end' for treating disease

Lecanemab was found to have reduced memory decline by targeting and clearing amyloid, which is one of the proteins that build up in the brains of people with the disease

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

New Alzheimer’s drug hailed as 'beginning of the end' in quest for treatment

Clinical results suggest that the disease progression can by slowed by 27%

Wales Online

Alzheimer's drug sparks hot debate over benefits as risks like brain bleeding emerge

Eisai Co. unveiled much-anticipated findings on its experimental Alzheimer’s drug, providing tinder for the hot debate over whether its modest efficacy is worth potential risks that include serious brain bleeding.

Tribune News Service

Why This New Alzheimer's Update Is Likely To Spark A Debate For Biogen Investors

Biogen stock surged Wednesday after partner Eisai unveiled Alzheimer's treatment test results that two doctors reportedly described as "magnificent."

Investors Business Daily

New Alzheimer’s drug hailed as ‘beginning of the end’ in search for treatment

Lecanemab was found to slow decline in patients’ memory and thinking.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Scientists hail major breakthrough in fight against Alzheimer’s as drug proven to slow disease

‘This is the first drug that provides a real treatment option,’ says leading researcher

The Independent UK

Drug slows Alzheimer's but can it make a real difference?

New data shows an experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening

The Independent UK

Drug slows cognitive decline in Alzheimer’s patients, study reveals

Antibody therapy lecanemab removes clumps of protein called beta amyloid that builds up in brain

The Guardian - UK

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Alzheimer Research UK

115 stories

Eisai

93 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.